GLI1 and ovarian carcinoma: To confirm that the reduction of cell proliferation in vitro by KAAD-cyclopamine was due to specific inhibition of the Hh pathway, we analyzed the change in mRNA and protein Gli1 levels in drug-treated ovarian carcinoma cell lines.